or Try an Advanced Search...

    ETF Components for PJP - PowerShares Dynamic Pharmaceuticals


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    ABT B 0.43 5.77
    JNJ D -0.21 5.29
    CORT B 2.90 5.29
    AMGN D 1.60 5.13
    PFE D 2.07 5.12
    ABBV D 3.04 4.91
    MRK F -0.68 4.79
    LLY F -0.25 4.67
    BMY B 1.10 4.07
    GILD C 0.48 4.00
    PBH A 0.84 3.82
    PCRX C 0.98 3.78
    UTHR C 1.51 3.70
    REGN F -0.87 3.69
    LGND B 2.27 3.63
    JAZZ B 1.25 3.62
    VTRS A 0.91 3.61
    AMRX C 0.84 3.55
    SUPN C 1.12 3.47
    INVA D 0.47 3.37
    ANIP F 1.88 3.12
    AMPH D 2.04 3.11
    PRGO B 3.66 3.08
    BIIB F -0.07 2.71
    GERN D 1.24 2.66

    Represented by ETF Holdings

    Keywords: Pharmaceutical Products S&P 500 Medicine Biotechnology Pain Pharmaceutical Diabetes Hypertension Infectious Diseases Biopharmaceutical Drugs Inflammation Alzheimer's Disease Animal Health Antibiotics Depression Depressive Disorder Nasdaq 100 Pharmacology Pulmonary Arterial Hypertension
    Industries: Drug Manufacturers - Major Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices Medical Distribution

    Recent News for PowerShares Dynamic Pharmaceuticals & its Holdings

    Date Stock Title
    Nov 23 MRK Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
    Nov 23 JNJ Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
    Nov 22 LLY Sanofi Plans to Change Hospital Drug-Discount Program
    Nov 22 MRK Merck recommends rejection of TRC Capital’s 'mini-tender' offer
    Nov 22 ABBV AbbVie gains on Leerink Partners upgrade to Outperform
    Nov 22 MRK Merck Recommends Rejection of TRC Capital’s "Mini-Tender" Offer
    Nov 22 ABBV AbbVie: Upgrading To 'Strong Buy' After Pullback
    Nov 22 PFE Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
    Nov 22 JNJ Layoffs in 2024: A List of Companies Cutting Jobs This Year
    Nov 22 PFE BridgeBio heart drug approved by FDA, setting up battle with Pfizer
    Nov 22 PFE Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
    Nov 22 PFE FDA Accepts Bayer's Application for Label Expansion of Nubeqa
    Nov 22 PFE Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)
    Nov 22 ABBV J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
    Nov 22 JNJ J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
    Nov 22 ABT 2 Dividend Kings to Buy for a Lifetime of Passive Income
    Nov 22 JNJ Medtronic acquires Fortimedix Surgical to boost surgical portfolio
    Nov 22 JNJ Sanofi Plans to Change Hospital Drug-Discount Program
    Nov 22 CORT Corcept Shares Rise More Than 60% in Three Months: Here's Why
    Nov 22 ABBV AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
    The PowerShares Dynamic Pharmaceuticals Portfolio (Fund) is based on the Dynamic Pharmaceutical IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
    Exchange Traded Fund ETF Exchange Traded Funds Pharmaceutical Invesco Powershares Inter 10 Index
    Back to the Main PJP Page...